Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
ProShares VIX Short-Term Futures ETF
VIXY
$183M
| $20K | ﹤0.01% |
+1
| New | +$32.3K |
|
|
WSR
5677
DELISTED
Whitestone REIT
WSR
| $20K | ﹤0.01% |
1,366
+90
| +7% | +$1.41K |
|
|
JOYY
5678
JOYY Inc
JOYY
$3.75B
| $20K | ﹤0.01% |
377
-19,287
| -98% | -$1.2M |
|
|
CEL
5679
DELISTED
Cellcom Israel, Ltd.
CEL
| $20K | ﹤0.01% |
5,062
+4,677
| +1,215% | +$26.8K |
|
|
CETV
5680
DELISTED
Central European Media Enterprises Ltd
CETV
| $20K | ﹤0.01% |
9,943
-1,002
| -9% | -$2.75K |
|
|
AVX
5681
DELISTED
AVX Corporation
AVX
| $20K | ﹤0.01% |
1,458
-2,989
| -67% | -$41.2K |
|
|
AREX
5682
DELISTED
Approach Resources Inc.
AREX
| $20K | ﹤0.01% |
3,432
-381
| -10% | -$2.62K |
|
|
PETX
5683
DELISTED
Aratana Therapeutics, Inc.
PETX
| $20K | ﹤0.01% |
1,252
-8,084
| -87% | -$144K |
|
|
ZSPH
5684
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $20K | ﹤0.01% |
477
-78
| -14% | -$3.57K |
|
|
STRZA
5685
PUT
DELISTED
Starz - Series A
STRZA
| $20K | ﹤0.01% |
600
-900
| -60% | -$28.2K |
|
|
DGI
5686
CALL
DELISTED
DigitalGlobe Inc.
DGI
| $20K | ﹤0.01% |
600
-3,300
| -85% | -$103K |
|
5687
AerCap
AER
$23.8B
| $19K | ﹤0.01% |
+450
| New | +$19K |
|
|
AMWD
5688
DELISTED
American Woodmark
AMWD
| $19K | ﹤0.01% |
367
-333
| -48% | -$15.3K |
|
5689
PUT
AptarGroup
ATR
$8.61B
| $19K | ﹤0.01% |
300
+200
| +200% | +$12.9K |
|
5690
Customers Bancorp
CUBI
$2.77B
| $19K | ﹤0.01% |
767
-602
| -44% | -$13K |
|
|
DX
5691
Dynex Capital
DX
$3.21B
| $19K | ﹤0.01% |
784
-697
| -47% | -$17.5K |
|
5692
CALL
EnerSys
ENS
$6.99B
| $19K | ﹤0.01% |
300
-2,700
| -90% | -$169K |
|
5693
First Bancorp
FBP
$4.38B
| $19K | ﹤0.01% |
3,136
-5,331
| -63% | -$32.4K |
|
5694
Fabrinet
FN
$20.1B
| $19K | ﹤0.01% |
1,054
-9,146
| -90% | -$160K |
|
5695
IAMGOLD
IAG
$10.5B
| $19K | ﹤0.01% |
18,958
+5,941
| +46% | +$14.6K |
|
5696
iShares Core S&P US Value ETF
IUSV
$27.7B
| $19K | ﹤0.01% |
429
| – | – |
|
5697
Lakeland Financial Corp
LKFN
$1.53B
| $19K | ﹤0.01% |
744
-1,271
| -63% | -$34K |
|
5698
CALL
Liquidity Services
LQDT
$1.32B
| $19K | ﹤0.01% |
2,100
-65,700
| -97% | -$591K |
|
5699
MYR Group
MYRG
$5.25B
| $19K | ﹤0.01% |
644
-1,087
| -63% | -$29.5K |
|
5700
National Bank Holdings
NBHC
$1.9B
| $19K | ﹤0.01% |
1,046
-1,070
| -51% | -$19.9K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.